HemaSphere (Jun 2022)

P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE

  • M. Wang,
  • M. Mei,
  • P. M. Barr,
  • J. Barrientos,
  • S. de Vos,
  • R. Furman,
  • K. Patel,
  • P. A. Thompson,
  • M. Choi,
  • A. Kallam,
  • Y. Zhu,
  • S. Chakraborty,
  • P. Marinello,
  • S. E. Spurgeon

DOI
https://doi.org/10.1097/01.HS9.0000847788.96420.63
Journal volume & issue
Vol. 6
pp. 1116 – 1117

Abstract

Read online

No abstracts available.